Detalles de la búsqueda
1.
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches.
Antimicrob Agents Chemother
; 67(4): e0145222, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36946729
2.
Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.
Antimicrob Agents Chemother
; 63(6)2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30962339
3.
In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program.
Antimicrob Agents Chemother
; 61(12)2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28971877
4.
In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014.
Antimicrob Agents Chemother
; 61(4)2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28167542
5.
Gepotidacin (GSK2140944) In Vitro Activity against Gram-Positive and Gram-Negative Bacteria.
Antimicrob Agents Chemother
; 61(7)2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28483959
6.
In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae.
Antimicrob Agents Chemother
; 61(3)2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28069643
7.
Update of the activity of telavancin against a global collection of Staphylococcus aureus causing bacteremia, including endocarditis (2011-2014).
Eur J Clin Microbiol Infect Dis
; 36(6): 1013-1017, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28111724
8.
Erratum for Pfaller et al., "In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014".
Antimicrob Agents Chemother
; 62(2)2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29371227
9.
Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010-2019).
J Chemother
; 35(8): 689-699, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37746914
10.
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
Antimicrob Agents Chemother
; 52(8): 2943-6, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18490501
11.
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
Int J Antimicrob Agents
; 51(2): 181-189, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28993143
12.
Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014.
Diagn Microbiol Infect Dis
; 91(2): 199-204, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567128
13.
Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015).
Diagn Microbiol Infect Dis
; 91(1): 77-84, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29395713
14.
Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?
Clin Infect Dis
; 45(9): 1171-8, 2007 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17918078
15.
Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principles.
J Chemother
; 19(1): 38-43, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17309849
16.
Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Australia and New Zealand: Report from an Antimicrobial Surveillance Program (2013-2015).
J Glob Antimicrob Resist
; 10: 186-194, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28735046
17.
Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014).
Diagn Microbiol Infect Dis
; 88(2): 177-183, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28341098
18.
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).
Clin Microbiol Infect
; 12(4): 315-21, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16524407
19.
Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
Clin Microbiol Infect
; 12(9): 844-52, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16882289
20.
Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
Int J Infect Dis
; 10(1): 56-60, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16326126